<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6742362\results\search\disease\results.xml">
  <result pre="Biology : Population Metrics: Age Distribution The epidemiological signature of" exact="influenza" post="B virus and its B/Victoria and B/Yamagata lineages in"/>
  <result pre="B/Victoria and B/Yamagata lineages in the 21st century Epidemiology of" exact="influenza" post="B virus and its lineages http://orcid.org/0000-0002-2262-1102CainiSaverioConceptualizationData curationFormal analysisInvestigationMethodologyVisualizationWriting –"/>
  <result pre="the epidemiological characteristics, pattern of circulation, and geographical distribution of" exact="influenza" post="B viruses and its lineages using data from the"/>
  <result pre="the Global Influenza B Study. We included over 1.8 million" exact="influenza" post="cases occurred in thirty-one countries during 2000–2018. We calculated"/>
  <result pre="during 2000–2018. We calculated the proportion of cases caused by" exact="influenza" post="B and its lineages; determined the timing of influenza"/>
  <result pre="by influenza B and its lineages; determined the timing of" exact="influenza" post="A and B epidemics; compared the age distribution of"/>
  <result pre="lineage-level mismatch for the trivalent vaccine. The median proportion of" exact="influenza" post="cases caused by influenza B virus was 23.4%, with"/>
  <result pre="trivalent vaccine. The median proportion of influenza cases caused by" exact="influenza" post="B virus was 23.4%, with a tendency (borderline statistical"/>
  <result pre="type in about one every seven seasons. In temperate countries," exact="influenza" post="B epidemics occurred on average three weeks later than"/>
  <result pre="influenza B epidemics occurred on average three weeks later than" exact="influenza" post="A epidemics; no consistent pattern emerged in the tropics."/>
  <result pre="tropics. The two B lineages caused a comparable proportion of" exact="influenza" post="B cases globally, however the B/Yamagata was more frequent"/>
  <result pre="tropics. The type B virus caused a substantial proportion of" exact="influenza" post="infections globally in the 21st century, and its two"/>
  <result pre="on populations globally [1]. The impact of seasonal and pandemic" exact="influenza" post="on population health in high-income countries has been described"/>
  <result pre="in high-income countries has been described extensively [2]. In Europe," exact="influenza" post="ranks first among infectious diseases in terms of burden,"/>
  <result pre="has been accumulating that the burden of disease associated with" exact="influenza" post="is high in low- and middle-income countries as well"/>
  <result pre="middle-income countries as well [4]. Type A viruses cause most" exact="influenza" post="cases and are responsible for pandemics, but influenza B"/>
  <result pre="cause most influenza cases and are responsible for pandemics, but" exact="influenza" post="B is an important cause of morbidity and mortality"/>
  <result pre="co-circulated globally in the 21st century [8–9]. The mainstay of" exact="influenza" post="prevention is vaccination, aimed primarily at individuals who are"/>
  <result pre="ensure adequate immunity against influenza; thus, investigating the timing of" exact="influenza" post="epidemics and the patterns of circulation of the different"/>
  <result pre="influenza epidemics and the patterns of circulation of the different" exact="influenza" post="virus types, subtypes and lineages is of great importance"/>
  <result pre="importance from a public health perspective [11]. Until 2012, trivalent" exact="influenza" post="vaccines (TIV) were available that contained only one type"/>
  <result pre="vaccines (TIV) were available that contained only one type B" exact="influenza" post="virus, belonging to either the B/Victoria or B/Yamagata lineage."/>
  <result pre="the mismatched lineage [12], and substantial health impact [13]. Quadrivalent" exact="influenza" post="vaccine (QIV), containing one B/Victoria and one B/Yamagata virus"/>
  <result pre="describe the epidemiology, clinical characteristics and burden of disease of" exact="influenza" post="B in more depth, and to compare the cost-effectiveness"/>
  <result pre="settings and populations. Despite significant advances in our understanding of" exact="influenza" post="B [14], important knowledge gaps persist, in particular concerning"/>
  <result pre="for instance in order to evaluate the cost-effectiveness of alternative" exact="influenza" post="prevention strategies and thus enable more appropriate public health"/>
  <result pre="Here, we conducted a global analysis of the epidemiology of" exact="influenza" post="B virus and its lineages using the database of"/>
  <result pre="detail elsewhere [14,23–24]. The GIBS database encompasses epidemiological and virological" exact="influenza" post="surveillance data from thirty-one countries around the world (Fig"/>
  <result pre="population centre [25]. Participating countries were required to make available" exact="influenza" post="surveillance data for as many consecutive years as possible"/>
  <result pre="(from 2000 onwards). Data include the weekly number of laboratory-confirmed" exact="influenza" post="cases broken down by virus type (A, B), type"/>
  <result pre="age groups) was also available. In most participating countries, the" exact="influenza" post="surveillance system covers the whole national territory, and a"/>
  <result pre="system covers the whole national territory, and a sample of" exact="influenza" post="virus positive specimens or virus isolates is routinely sent"/>
  <result pre="The GIBS database was initially assembled in 2013–14 by merging" exact="influenza" post="surveillance data up to as late as December 2013"/>
  <result pre="20 weeks of reported data and at least 100 laboratory-confirmed" exact="influenza" post="cases. In each season, we calculated the percentage of"/>
  <result pre="influenza cases. In each season, we calculated the percentage of" exact="influenza" post="cases that were due to influenza B. We then"/>
  <result pre="calculated the percentage of influenza cases that were due to" exact="influenza" post="B. We then determined the percentage of cases that"/>
  <result pre="country) the subset of seasons with 50 or more characterized" exact="influenza" post="B viruses. The non-parametric Kruskal-Wallis test was applied to"/>
  <result pre="Kruskal-Wallis test was applied to compare the median proportion of" exact="influenza" post="A and B cases (over all influenza cases) and"/>
  <result pre="median proportion of influenza A and B cases (over all" exact="influenza" post="cases) and B/Victoria and B/Yamagata cases (over all cases"/>
  <result pre="and B/Victoria and B/Yamagata cases (over all cases with characterized" exact="influenza" post="B viruses) between countries based on their latitude (Northern"/>
  <result pre="[25]. We compared the timing of the primary peak of" exact="influenza" post="A and B epidemics in each country using the"/>
  <result pre="hemisphere countries) because of the markedly atypical timing of the" exact="influenza" post="A(H1N1)pdm09 pandemics. Time series were first standardized by dividing"/>
  <result pre="series were first standardized by dividing the weekly number of" exact="influenza" post="cases by the maximum weekly number (per country by"/>
  <result pre="in each country. We aimed to evaluated the frequency of" exact="influenza" post="B lineage-level vaccine mismatch, which was defined as a"/>
  <result pre="mismatch between the lineage that caused the majority (&amp;gt;50%) of" exact="influenza" post="B cases in a given season and country, and"/>
  <result pre="and the lineage included in the trivalent vaccine. Information on" exact="influenza" post="vaccine formulation was retrieved from the WHO website [27]."/>
  <result pre="belt. While the WHO issues recommendations on the composition of" exact="influenza" post="vaccines to be used in tropical countries [28], these"/>
  <result pre="the resulting increase in the number of cases with characterized" exact="influenza" post="B viruses made it possible to compare the age"/>
  <result pre="viruses made it possible to compare the age distribution of" exact="influenza" post="B/Victoria and B/Yamagata cases in a similar way to"/>
  <result pre="a similar way to what had been done previously for" exact="influenza" post="B vs. A (and its subtypes) [14,24]. This analysis"/>
  <result pre="for at least 50 B/Victoria and at least 50 B/Yamagata" exact="influenza" post="cases over all seasons available. The virus-lineage-specific age distribution"/>
  <result pre="cases over all seasons available. The virus-lineage-specific age distribution of" exact="influenza" post="B cases was visualized, separately in each country, using"/>
  <result pre="Wilcoxon rank sum test to compare the median age of" exact="influenza" post="B cases by virus lineage. Statistical analyses were conducted"/>
  <result pre="the Global Influenza B Study encompassed a total of 1.820.301" exact="influenza" post="cases between 2000 and 2018, of which 419,167 (23.0%)"/>
  <result pre="with USA and Australia contributing 54.1% and 25.3% of all" exact="influenza" post="cases to the database, respectively. Information on age was"/>
  <result pre="remaining countries, information on age was available for most (95.0%)" exact="influenza" post="cases. After applying our exclusion criteria, 299 seasons with"/>
  <result pre="our exclusion criteria, 299 seasons with 100 or more reported" exact="influenza" post="cases overall were included in the analysis, of which"/>
  <result pre="to eighteen (for New Zealand). The number of overall and" exact="influenza" post="B cases in each country and season included in"/>
  <result pre="country and season included in the analysis, the proportion of" exact="influenza" post="B cases of which the virus was characterized, and"/>
  <result pre="and B/Yamagata lineages, are provided in S1 Table. Frequency of" exact="influenza" post="B Influenza B virus caused a median 23.4% (interquartile"/>
  <result pre="caused a median 23.4% (interquartile range [IQR] 9.3–38.9%) of reported" exact="influenza" post="cases in a season. More specifically, the proportion of"/>
  <result pre="influenza cases in a season. More specifically, the proportion of" exact="influenza" post="cases caused by the B virus type was &amp;lt;20%"/>
  <result pre="and above 50% in 45 seasons (15.1%). The proportion of" exact="influenza" post="B cases over all influenza cases reported in the"/>
  <result pre="seasons (15.1%). The proportion of influenza B cases over all" exact="influenza" post="cases reported in the season varied geographically (Fig 2):"/>
  <result pre="(22.2%, IQR 9.1–34.5%) hemispheres. The proportion of seasons in which" exact="influenza" post="B cases constituted between 20 and 50% or more"/>
  <result pre="20 and 50% or more than 50% of all reported" exact="influenza" post="cases did not significantly differ (p = 0.275) between"/>
  <result pre="two hemispheres (39.9% and 14.3%, respectively). Fig 2 Distribution of" exact="influenza" post="seasons by proportion of influenza B cases and geographical"/>
  <result pre="respectively). Fig 2 Distribution of influenza seasons by proportion of" exact="influenza" post="B cases and geographical area (Inter-tropical belt, Northern hemisphere,"/>
  <result pre="75th percentiles. The Global Influenza B Study, 2000–2018. Timing of" exact="influenza" post="A and B epidemics In countries of the Southern"/>
  <result pre="A and B epidemics In countries of the Southern hemisphere," exact="influenza" post="A epidemics typically peaked in July-September, on average 1.1"/>
  <result pre="typically peaked in July-September, on average 1.1 month earlier than" exact="influenza" post="B (August-September) (Table 1). Influenza epidemics also peaked in"/>
  <result pre="in the winter months of Northern hemisphere countries, earlier for" exact="influenza" post="A (January-February, except Ukraine, in March) than for influenza"/>
  <result pre="for influenza A (January-February, except Ukraine, in March) than for" exact="influenza" post="B (February-March, except England, in January), with an average"/>
  <result pre="countries among those situated in the Northern hemisphere), where both" exact="influenza" post="A and B epidemics typically peaked in August. There"/>
  <result pre="(0.3 months earlier on average) for the primary peak of" exact="influenza" post="A and B epidemics. 10.1371/journal.pone.0222381.t001Table 1 Typical timing of"/>
  <result pre="B epidemics. 10.1371/journal.pone.0222381.t001Table 1 Typical timing of the peak of" exact="influenza" post="A and B epidemics according to countries’ latitude. The"/>
  <result pre="Global Influenza B Study, 2000–2018. Country Latitude Typical timing of" exact="influenza" post="peak A B Southern hemisphere New Zealand 41.8 S"/>
  <result pre="where the virus lineage was determined for 50 or more" exact="influenza" post="B cases (out of a total 299 seasons, 28.1%)"/>
  <result pre="B/Yamagata lineage viruses caused a similar range of proportions of" exact="influenza" post="B cases. More precisely, the median proportion of influenza"/>
  <result pre="of influenza B cases. More precisely, the median proportion of" exact="influenza" post="B cases reported in a season that were caused"/>
  <result pre="5.3–89.6%). The range of the proportion of B/Victoria over all" exact="influenza" post="B cases was 0%-100%, meaning that there were seasons"/>
  <result pre="was 0%-100%, meaning that there were seasons in which all" exact="influenza" post="B cases were caused by either virus lineage. Co-circulation"/>
  <result pre="84 seasons, both lineages accounted for at least 20% of" exact="influenza" post="B cases, while the B/Victoria and B/Yamagata lineages caused"/>
  <result pre="the B/Victoria and B/Yamagata lineages caused over 80% of all" exact="influenza" post="B cases in 27 (32.1%) and 30 (35.8%) seasons,"/>
  <result pre="(35.8%) seasons, respectively. The proportion of either lineage over all" exact="influenza" post="B cases varied according to the age structure of"/>
  <result pre="the countries’ latitude as well (Fig 3). The proportion of" exact="influenza" post="B cases caused by the B/Victoria lineage in a"/>
  <result pre="a median age below 30 years (median proportion over all" exact="influenza" post="B cases = 67.0%) compared to countries with a"/>
  <result pre="(36.2%). Likewise, the median proportion of B/Victoria over all characterized" exact="influenza" post="B cases in a season was higher in countries"/>
  <result pre="Southern hemisphere (43.8%) (p-value = 0.048). Fig 3 Proportion of" exact="influenza" post="B cases in a season that were caused by"/>
  <result pre="Influenza B Study, 2000–2018. Age distribution of B/Victoria and B/Yamagata" exact="influenza" post="cases In Table 2, we compared the median age"/>
  <result pre="cases In Table 2, we compared the median age of" exact="influenza" post="B cases according to virus lineage. In Australia, B/Victoria"/>
  <result pre="and in Ukraine (p-value 0.082). 10.1371/journal.pone.0222381.t002Table 2 Age distribution of" exact="influenza" post="B/Victoria and B/Yamagata patients by country (sorted by median"/>
  <result pre="B Study, 2000–2018. Country (a) Median age general population No." exact="influenza" post="B cases Median age (IQR) Victoria Yamagata Victoria Yamagata"/>
  <result pre="was available for ≥50 B Victoria and ≥50 B Yamagata" exact="influenza" post="cases. (b) Wilcoxon rank-sum test for comparison of medians"/>
  <result pre="of B/Victoria and B/Yamagata cases (S1 File). In most countries," exact="influenza" post="B/Victoria cases tended to be distributed according to their"/>
  <result pre="peaking at above 50 years of age. Frequency of lineage-level" exact="influenza" post="B trivalent vaccine mismatches The proportion of influenza B"/>
  <result pre="of lineage-level influenza B trivalent vaccine mismatches The proportion of" exact="influenza" post="B lineage-level vaccine mismatch was 54.2% in countries in"/>
  <result pre="composition for the Southern hemisphere. Discussion Our analysis found that" exact="influenza" post="B virus was responsible for nearly one fourth of"/>
  <result pre="B virus was responsible for nearly one fourth of all" exact="influenza" post="cases in an average season between 2000 and 2018."/>
  <result pre="in an average season between 2000 and 2018. More specifically," exact="influenza" post="B virus accounted for over 20% of all influenza"/>
  <result pre="specifically, influenza B virus accounted for over 20% of all" exact="influenza" post="cases in more than half of the seasons, and"/>
  <result pre="seven seasons. This proportion varied geographically, as the proportion of" exact="influenza" post="B over all influenza cases tended to be higher"/>
  <result pre="varied geographically, as the proportion of influenza B over all" exact="influenza" post="cases tended to be higher on average in tropical"/>
  <result pre="epidemics tended to peak on average three weeks later than" exact="influenza" post="A epidemics during the winter period in temperate countries"/>
  <result pre="is consistent with previous country reports [21,30,32–34]. The timing of" exact="influenza" post="A and B epidemics was different in tropical countries"/>
  <result pre="weather conditions that are most favourable to the occurrence of" exact="influenza" post="epidemics (e.g. cold-dry) last for only a limited number"/>
  <result pre="area (i.e. anywhere around the world seasons occurred where all" exact="influenza" post="B cases were caused by either the B/Victoria or"/>
  <result pre="faced when trying to predict which lineage will cause most" exact="influenza" post="B cases next season. This helps explain the very"/>
  <result pre="that whilst the two lineages caused a comparable proportion of" exact="influenza" post="B cases globally during the study period, their distribution"/>
  <result pre="&quot;cold-dry�? and &quot;humid-rainy�? environmental conditions that drive the occurrence of" exact="influenza" post="epidemics in temperate and tropical countries, respectively [38]. This"/>
  <result pre="be supported by the available evidence, which suggests instead that" exact="influenza" post="viruses of different types and subtypes (e.g. A(H3N2), A(H1N1)pdm09,"/>
  <result pre="that differ greatly under many aspects, including the type of" exact="influenza" post="surveillance system) that B/Yamagata cases are on average older"/>
  <result pre="patients. Importantly, our findings support earlier work showing that each" exact="influenza" post="A subtype (H3N2, pre-2009-pandemic H1N1, and H1N1pdm09) tends to"/>
  <result pre="viruses [41]. Finally, antigenic original sin (i.e. preferential response to" exact="influenza" post="B viruses encountered in the past [42]) may also"/>
  <result pre="These findings have important implications for assessing the impact of" exact="influenza" post="B viruses in a population each season. Knowing early"/>
  <result pre="season. Knowing early in the season (through surveillance activities) which" exact="influenza" post="B lineage virus is circulating will allow one to"/>
  <result pre="was a lineage-level vaccine mismatch) and a high burden of" exact="influenza" post="B was observed in many European countries [43]. We"/>
  <result pre="B was observed in many European countries [43]. We analyzed" exact="influenza" post="surveillance data from around the world to determine the"/>
  <result pre="data from around the world to determine the epidemiology of" exact="influenza" post="B virus and its lineages in the 21st century."/>
  <result pre="lineages, thus achieving a better understanding of the epidemiology of" exact="influenza" post="B globally. The most important limitation of our study"/>
  <result pre="included, number of years with data and average number of" exact="influenza" post="cases reported per year, proportion of influenza B viruses"/>
  <result pre="average number of influenza cases reported per year, proportion of" exact="influenza" post="B viruses that were characterized availability of information on"/>
  <result pre="intensity of surveillance activities, and the coverage of each country’s" exact="influenza" post="surveillance system. Throughout this paper, we have used statistical"/>
  <result pre="of analysis for the comparison of the frequency of B" exact="influenza" post="across countries, the standardization offered by the EPIPOI software"/>
  <result pre="the EPIPOI software in the analysis of temporal patterns of" exact="influenza" post="epidemics, and the use of medians to compare the"/>
  <result pre="the use of medians to compare the age distribution of" exact="influenza" post="cases between countries. However, we acknowledge that these sources"/>
  <result pre="quantify precisely, and a further improvement in the harmonization of" exact="influenza" post="surveillance data remains desirable as it would allow researchers"/>
  <result pre="study provides important new information that describes the epidemiology of" exact="influenza" post="B viruses and its lineages during the start of"/>
  <result pre="during the start of the 21st century. We showed that" exact="influenza" post="B virus caused nearly one fourth (on average) of"/>
  <result pre="B virus caused nearly one fourth (on average) of all" exact="influenza" post="cases occurring annually in the world during 2000–2018, and"/>
  <result pre="both lineages accounted each for a comparable proportion of all" exact="influenza" post="B cases globally. We also observed that cases infected"/>
  <result pre="our knowledge of the epidemiology and pattern of circulation of" exact="influenza" post="B virus, these findings will help inform health policy"/>
  <result pre="policy decisions aiming to reduce disease burden associated with seasonal" exact="influenza" post="locally, regionally and globally. Supporting information S1 Table Laboratory-confirmed"/>
  <result pre="influenza locally, regionally and globally. Supporting information S1 Table Laboratory-confirmed" exact="influenza" post="cases reported in each country and season, and proportion"/>
  <result pre="country and season, and proportion of those caused by the" exact="influenza" post="B virus type (overall and by lineage). The Global"/>
  <result pre="year for other countries. (b) Seasons with fewer than 100" exact="influenza" post="cases were not included. (c) Number of influenza B"/>
  <result pre="than 100 influenza cases were not included. (c) Number of" exact="influenza" post="B cases in each season, and proportion of influenza"/>
  <result pre="of influenza B cases in each season, and proportion of" exact="influenza" post="B over all influenza cases in the same season."/>
  <result pre="in each season, and proportion of influenza B over all" exact="influenza" post="cases in the same season. (d) Number of influenza"/>
  <result pre="all influenza cases in the same season. (d) Number of" exact="influenza" post="B cases for which the virus lineage was characterized,"/>
  <result pre="which the virus lineage was characterized, and proportion over all" exact="influenza" post="B cases in the same season. (e) Number of"/>
  <result pre="influenza B cases in the same season. (e) Number of" exact="influenza" post="B cases caused by viruses belonging to the Victoria"/>
  <result pre="the Victoria and Yamagata lineages, and proportion over all characterized" exact="influenza" post="B viruses in the same season. Not reported in"/>
  <result pre="season. Not reported in seasons with fewer than 50 characterized" exact="influenza" post="B cases. (DOCX) LINK Click here for additional data"/>
  <result pre="for additional data file. S1 File Age distribution of laboratory-confirmed" exact="influenza" post="patients infected with type B viruses belonging to the"/>
  <result pre="exact age for ≥50 B Victoria and ≥50 B Yamagata" exact="influenza" post="for the whole study period cases were included. Countries"/>
  <result pre="FlanneryB, BrammerL, SingletonJAet al.Annual estimates of the burden of seasonal" exact="influenza" post="in the United States: A tool for strengthening influenza"/>
  <result pre="seasonal influenza in the United States: A tool for strengthening" exact="influenza" post="surveillance and preparedness. Influenza Other Respir Viruses. 2018;12(1):132–137. 10.1111/irv.1248629446233"/>
  <result pre="4LeeVJ, HoZJM, GohEH, CampbellH, CohenC, CozzaV, et al.Advances in measuring" exact="influenza" post="burden of disease. Influenza Other Respir Viruses. 2018;12(1):3–9. 10.1111/irv.1253329460425"/>
  <result pre="10.1111/irv.1253329460425 5Paul GlezenW, SchmierJK, KuehnCM, RyanKJ, OxfordJ. The burden of" exact="influenza" post="B: a structured literature review. Am J Public Health."/>
  <result pre="RotaJS, KendalAP, NeromeK. Cocirculation of two distinct evolutionary lineages of" exact="influenza" post="type B virus since 1983. Virology. 1990;175(1):59–68. 10.1016/0042-6822(90)90186-u2309452 8PaivaTM,"/>
  <result pre="BenegaMA, SilvaDB, SantosKC, CruzAS, HortenciMF, et al.Evolutionary pattern of reemerging" exact="influenza" post="B/Victoria lineage viruses in São Paulo, Brazil, 1996–2012: Implications"/>
  <result pre="LeePI, KimWJ, BuchyP, et al.Literature review of the epidemiology of" exact="influenza" post="B disease in 15 countries in the Asia-Pacific region."/>
  <result pre="ScienceM, KusterSP, et al.Populations at risk for severe or complicated" exact="influenza" post="illness: systematic review and meta-analysis. BMJ. 2013;347:f506110.1136/bmj.f506123974637 11CainiS, SchellevisF,"/>
  <result pre="SchellevisF, El-Guerche SéblainC, PagetJ. Important changes in the timing of" exact="influenza" post="epidemics in the WHO European Region over the past"/>
  <result pre="Surveill. 2018;23(1). 12TriccoAC, ChitA, SoobiahC, HallettD, MeierG, ChenMH, et al.Comparing" exact="influenza" post="vaccine efficacy against mismatched and matched strains: a systematic"/>
  <result pre="and meta-analysis. BMC Med. 2013;11:15310.1186/1741-7015-11-15323800265 13HeikkinenT, IkonenN, ZieglerT. Impact of" exact="influenza" post="B lineage-level mismatch between trivalent seasonal influenza vaccines and"/>
  <result pre="ZieglerT. Impact of influenza B lineage-level mismatch between trivalent seasonal" exact="influenza" post="vaccines and circulating viruses, 1999–2012. Clin Infect Dis. 2014;59(11):1519–24."/>
  <result pre="CiblakMA, KusznierzG, OwenR, WangchukS, et al.Epidemiological and virological characteristics of" exact="influenza" post="B: results of the Global Influenza B Study. Influenza"/>
  <result pre="al.A systematic review of the health economic consequences of quadrivalent" exact="influenza" post="vaccination. Expert Rev Pharmacoecon Outcomes Res. 2017;17(3):249–265. 10.1080/14737167.2017.134314528613092 16So�?anM,"/>
  <result pre="A comparison of the demographic and clinical characteristics of laboratory-confirmed" exact="influenza" post="B Yamagata and Victoria lineage infection. J Clin Virol."/>
  <result pre="17LeTT, PhamTH, PhamTH, Nguyen leKH, NguyenCT, HoangVM, et al.Circulation of" exact="influenza" post="B lineages in northern Viet Nam, 2007–2014. Western Pac"/>
  <result pre="18XuC, ChanKH, TsangTK, FangVJ, FungRO, IpDK, et al.Comparative epidemiology of" exact="influenza" post="B Yamagata- and Victoria-lineage viruses in households. Am J"/>
  <result pre="Epidemiol. 2015;182(8):705–13. 10.1093/aje/kwv11026400854 19BarrIG, VijaykrishnaD, SullivanSG. Differential age susceptibility to" exact="influenza" post="B/Victoria lineage viruses in the 2015 Australian influenza season."/>
  <result pre="susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian" exact="influenza" post="season. Euro Surveill. 2016;21(4). 20SelekaM, TreurnichtFK, TempiaS, HellfersceeO, MtshaliS,"/>
  <result pre="2016;21(4). 20SelekaM, TreurnichtFK, TempiaS, HellfersceeO, MtshaliS, CohenAL, et al.Epidemiology of" exact="influenza" post="B/Yamagata and B/Victoria lineages in South Africa, 2005–2014. PLoS"/>
  <result pre="2005–2014. PLoS One. 2017;12(5):e017765510.1371/journal.pone.017765528542324 21MoaAM, MuscatelloDJ, TurnerRM, MacIntyreCR. Epidemiology of" exact="influenza" post="B in Australia: 2001–2014 influenza seasons. Influenza Other Respir"/>
  <result pre="MuscatelloDJ, TurnerRM, MacIntyreCR. Epidemiology of influenza B in Australia: 2001–2014" exact="influenza" post="seasons. Influenza Other Respir Viruses. 2017;11(2):102–109. 10.1111/irv.1243227650482 22LapinsckiB, PereiraLA,"/>
  <result pre="22LapinsckiB, PereiraLA, NogueiraMB, VidalLR, RiedigerI, DeburMC, et al.Molecular epidemiology of" exact="influenza" post="B virus and implications in immunization strategy, Southern Brazil."/>
  <result pre="23CainiS, AndradeW, BadurS, BalmasedaA, BarakatA, BellaA, et al.Temporal patterns of" exact="influenza" post="A and B in tropical and temperate countries: what"/>
  <result pre="in tropical and temperate countries: what are the lessons for" exact="influenza" post="vaccination?PLoS One. 2016;11(3):e015231010.1371/journal.pone.015231027031105 24CainiS, SpreeuwenbergP, KusznierzGF, RudiJM, OwenR, PenningtonK,"/>
  <result pre="2016;11(3):e015231010.1371/journal.pone.015231027031105 24CainiS, SpreeuwenbergP, KusznierzGF, RudiJM, OwenR, PenningtonK, et al.Distribution of" exact="influenza" post="virus types by age using case-based global surveillance data"/>
  <result pre="Health. 2012;12(1):982.23153033 27World Health Organization. Recommendations on the composition of" exact="influenza" post="virus vaccines. http://www.who.int/influenza/vaccines/virus/recommendations/en/ Cited 18 June 2018 28World Health"/>
  <result pre="18 June 2018 29HirveS, LambachP, PagetJ, VandemaeleK, FitznerJ, ZhangW. Seasonal" exact="influenza" post="vaccine policy, use and effectiveness in the tropics and"/>
  <result pre="2016;10(4):254–67. 10.1111/irv.1237426842617 30MosnierA, CainiS, DaviaudI, BensoussanJL, Stoll-KellerF, BuiTT, et al.Ten" exact="influenza" post="seasons in France: distribution and timing of influenza A"/>
  <result pre="et al.Ten influenza seasons in France: distribution and timing of" exact="influenza" post="A and B circulation, 2003–2013. BMC Infect Dis. 2015;15:35710.1186/s12879-015-1056-z26289794"/>
  <result pre="Infect Dis. 2015;15:35710.1186/s12879-015-1056-z26289794 31BarrosEN, CintraO, RossettoE, FreitasL, ColindresR. Patterns of" exact="influenza" post="B circulation in Brazil and its relevance to seasonal"/>
  <result pre="YangP, QianH, ShiW, WuS, et al.Epidemiological and phylogenetic characteristics of" exact="influenza" post="B infection in severe acute respiratory infection cases in"/>
  <result pre="van GinkelA, SuijkerbuijkA, van der HoekW, et al.Early occurrence of" exact="influenza" post="A epidemics coincided with changes in occurrence of other"/>
  <result pre="10.1111/irv.1234826369646 34CainiS, AlonsoWJ, SéblainCE, SchellevisF, PagetJ. The spatiotemporal characteristics of" exact="influenza" post="A and B in the WHO European Region: can"/>
  <result pre="and B in the WHO European Region: can one define" exact="influenza" post="transmission zones in Europe?Euro Surveill. 2017;22(35). 35LaurieKL, GuarnacciaTA, CarolanLA,"/>
  <result pre="infections and viral hierarchy are determinants of viral interference following" exact="influenza" post="virus infection in a ferret model. J Infect Dis."/>
  <result pre="10.1093/infdis/jiv26025943206 36BelsheRB, CoelinghK, AmbroseCS, WooJC, WuX. Efficacy of live attenuated" exact="influenza" post="vaccine in children against influenza B viruses by lineage"/>
  <result pre="WuX. Efficacy of live attenuated influenza vaccine in children against" exact="influenza" post="B viruses by lineage and antigenic similarity. Vaccine. 2010;28(9):2149–56."/>
  <result pre="NguyenTP, MoyesJ, CohenC, et al.The cost-effectiveness of trivalent and quadrivalent" exact="influenza" post="vaccination in communities in South Africa, Vietnam and Australia."/>
  <result pre="ShamanJ, AlonsoWJ, Bloom-FeshbachK, UejioCK, ComrieA, et al.Environmental predictors of seasonal" exact="influenza" post="epidemics across temperate and tropical climates. PLoS Pathog. 2013;9(3):e100319410.1371/journal.ppat.100319423505366"/>
  <result pre="2013;9(3):e100319410.1371/journal.ppat.100319423505366 39LowenAC, SteelJ. Roles of humidity and temperature in shaping" exact="influenza" post="seasonality. J Virol. 2014;88(14):7692–5. 10.1128/JVI.03544-1324789791 40VijaykrishnaD, HolmesEC, JosephU, FourmentM,"/>
  <result pre="JosephU, FourmentM, SuYC, HalpinR, et al.The contrasting phylodynamics of human" exact="influenza" post="B viruses. Elife. 2015;4:e0505510.7554/eLife.0505525594904 41NyirendaM, OmoriR, TessmerHL, ArimuraH, ItoK."/>
  <result pre="OmoriR, TessmerHL, ArimuraH, ItoK. Estimating the lineage dynamics of human" exact="influenza" post="B viruses. PLoS One. 2016;11(11):e016610710.1371/journal.pone.016610727829058 42SkowronskiDM, HottesTS, De SerresG,"/>
  <result pre="MelidouA, IonescuS, Penttinen; collab: The European Influenza Surveillance Network. Dominant" exact="influenza" post="A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and"/>
 </snippets>
</snippetsTree>
